Skip to main content
Erschienen in: Endocrine Pathology 4/2014

01.12.2014

Case Report: Adrenal Oncocytoma Associated with Markedly Increased FDG Uptake and Immunohistochemically Positive for GLUT1

verfasst von: Naomi Sato, Yasuhiro Nakamura, Kentaro Takanami, Yoshikiyo Ono, Kei Omata, Ryo Morimoto, Fumitoshi Satoh, Kazue Ise, Shigeyuki Yamada, Atsuko Kasajima, Fumiyoshi Fujishima, Mika Watanabe, Yoichi Arai, Hironobu Sasano

Erschienen in: Endocrine Pathology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Usually, benign tumors are not associated with an increased F-18 fluorodeoxyglucose (F-18 FDG) uptake on positron emission tomography (PET), although some exceptions have been reported in adrenal neoplasms. We present a rare case of adrenocortical oncocytoma associated with markedly increased FDG uptake, demonstrating a maximum standardized uptake value of 46.8. Histological examination demonstrated diffuse proliferation of tumor cells with eosinophilic and granular cytoplasm that were diffusely immunopositive for mitochondria and glucose transport protein 1, with focal and weak immunopositivity for 3β-hydroxysteroid dehydrogenase. Ultrastructural examination also revealed abundant mitochondria in the tumor cells. The tumor was diagnosed as adrenocortical oncocytoma and was considered benign according to Lin-Weiss-Bisceglia criteria. Diagnosis of adrenocortical oncocytoma can pose difficulties during both preoperative radiological and postoperative histopathological investigations.
Literatur
1.
Zurück zum Zitat Mearini L, Del Sordo R, Costantini E, Nunzi E, Porena M (2013) Adrenal oncocytic neoplasm: a systematic review. Urol Int 91:125–133.PubMedCrossRef Mearini L, Del Sordo R, Costantini E, Nunzi E, Porena M (2013) Adrenal oncocytic neoplasm: a systematic review. Urol Int 91:125–133.PubMedCrossRef
2.
Zurück zum Zitat Wong DD, Spagnolo DV, Bisceglia M, Havlat M, McCallum D, Platten MA (2011) Oncocytic adrenocortical neoplasms--a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. Hum Pathol 42:489–499.PubMedCrossRef Wong DD, Spagnolo DV, Bisceglia M, Havlat M, McCallum D, Platten MA (2011) Oncocytic adrenocortical neoplasms--a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. Hum Pathol 42:489–499.PubMedCrossRef
3.
Zurück zum Zitat Sasano H, Suzuki T, Sano T, Kameya T, Sasano N, Nagura H (1991) Adrenocortical oncocytoma. A true nonfunctioning adrenocortical tumor. Am J Surg Pathol 15:949–956.PubMedCrossRef Sasano H, Suzuki T, Sano T, Kameya T, Sasano N, Nagura H (1991) Adrenocortical oncocytoma. A true nonfunctioning adrenocortical tumor. Am J Surg Pathol 15:949–956.PubMedCrossRef
4.
Zurück zum Zitat Kim DJ, Chung JJ, Ryu YH, Hong SW, Yu JS, Kim JH (2008) Adrenocortical oncocytoma displaying intense activity on 18F-FDG-PET: a case report and a literature review. Ann Nucl Med 22:821–824.PubMedCrossRef Kim DJ, Chung JJ, Ryu YH, Hong SW, Yu JS, Kim JH (2008) Adrenocortical oncocytoma displaying intense activity on 18F-FDG-PET: a case report and a literature review. Ann Nucl Med 22:821–824.PubMedCrossRef
5.
Zurück zum Zitat Acar C, Akkas BE, Sen I, Sozen S, Kitapci MT (2008) False positive 18F-FDG PET scan in adrenal oncocytoma. Urol Int 80:444–447.PubMedCrossRef Acar C, Akkas BE, Sen I, Sozen S, Kitapci MT (2008) False positive 18F-FDG PET scan in adrenal oncocytoma. Urol Int 80:444–447.PubMedCrossRef
6.
Zurück zum Zitat Minamimoto R, Yamanaka S, Kawamoto M, Endoh M, Nishito R, Yoshida K, Nakaigawa N, Yao M, Kubota Y, Inoue T (2007) High FDG uptake on oncocytoma located in the retroperitoneum mimicking malignancy. Clin Nucl Med 32:582–583.PubMedCrossRef Minamimoto R, Yamanaka S, Kawamoto M, Endoh M, Nishito R, Yoshida K, Nakaigawa N, Yao M, Kubota Y, Inoue T (2007) High FDG uptake on oncocytoma located in the retroperitoneum mimicking malignancy. Clin Nucl Med 32:582–583.PubMedCrossRef
7.
Zurück zum Zitat John N. Eble, Guido Sauter, Jonathan I. Epstein, Isabell A. Sesterhenn. World Health Organization Classification of Tumours (2004). Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARCPress 42. John N. Eble, Guido Sauter, Jonathan I. Epstein, Isabell A. Sesterhenn. World Health Organization Classification of Tumours (2004). Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARCPress 42.
8.
Zurück zum Zitat Leon Barnes, John W. Eveson, Peter Reichart, David Sidransky. World Health Organization Classification of Tumours (2005). Pathology and Genetics of Head and Neck Tumours. IARCPress 266. Leon Barnes, John W. Eveson, Peter Reichart, David Sidransky. World Health Organization Classification of Tumours (2005). Pathology and Genetics of Head and Neck Tumours. IARCPress 266.
9.
Zurück zum Zitat Duregon E, Volante M, Cappia S, Cuccurullo A, Bisceglia M, Wong DD, Spagnolo DV, Szpak-Ulczok S, Bollito E, Daffara F, Berruti A, Terzolo M, Papotti M (2011) Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases. Am J Surg Pathol 35:1882–1893.PubMedCrossRef Duregon E, Volante M, Cappia S, Cuccurullo A, Bisceglia M, Wong DD, Spagnolo DV, Szpak-Ulczok S, Bollito E, Daffara F, Berruti A, Terzolo M, Papotti M (2011) Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases. Am J Surg Pathol 35:1882–1893.PubMedCrossRef
10.
Zurück zum Zitat Lee R, Al-Ahmadie HA, Boorjian SA, Gonzalez RR, Badillo C, Badillo F, Reuter VE, Steckel J (2006) A case of incidental adrenocortical oncocytoma. Nat Clin Pract Urol 3:618–621.PubMedCrossRef Lee R, Al-Ahmadie HA, Boorjian SA, Gonzalez RR, Badillo C, Badillo F, Reuter VE, Steckel J (2006) A case of incidental adrenocortical oncocytoma. Nat Clin Pract Urol 3:618–621.PubMedCrossRef
11.
Zurück zum Zitat Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G, Lau SK, Weiss LM (2004) Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 12:231–243.PubMedCrossRef Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G, Lau SK, Weiss LM (2004) Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 12:231–243.PubMedCrossRef
12.
Zurück zum Zitat Bisceglia M, Ben-Dor D, Pasquinelli G (2005) Oncocytic Adrenocortical Tumors. Pathology Case Reviews 10 (5):228–242.CrossRef Bisceglia M, Ben-Dor D, Pasquinelli G (2005) Oncocytic Adrenocortical Tumors. Pathology Case Reviews 10 (5):228–242.CrossRef
13.
Zurück zum Zitat Sasano H, Suzuki T, Moriya T (2006) Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol 17:345–354.PubMedCrossRef Sasano H, Suzuki T, Moriya T (2006) Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol 17:345–354.PubMedCrossRef
14.
Zurück zum Zitat Schittenhelm J, Ebner FH, Harter P, Bornemann A (2009) Symptomatic intraspinal oncocytic adrenocortical adenoma. Endocr Pathol 20:73–77.PubMedCrossRef Schittenhelm J, Ebner FH, Harter P, Bornemann A (2009) Symptomatic intraspinal oncocytic adrenocortical adenoma. Endocr Pathol 20:73–77.PubMedCrossRef
15.
Zurück zum Zitat Hoang MP, Ayala AG, Albores-Saavedra J (2002) Oncocytic adrenocortical carcinoma: a morphologic, immunohistochemical and ultrastructural study of four cases. Mod Pathol 15:973–978.PubMedCrossRef Hoang MP, Ayala AG, Albores-Saavedra J (2002) Oncocytic adrenocortical carcinoma: a morphologic, immunohistochemical and ultrastructural study of four cases. Mod Pathol 15:973–978.PubMedCrossRef
16.
Zurück zum Zitat Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163–169.PubMedCrossRef Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163–169.PubMedCrossRef
17.
Zurück zum Zitat Ni J, Qiu LJ, Hu LF, Cen H, Zhang M, Wen PF, Wang XS, Pan HF, Ye DQ (2014) Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis. Lupus 23:284–292.PubMedCrossRef Ni J, Qiu LJ, Hu LF, Cen H, Zhang M, Wen PF, Wang XS, Pan HF, Ye DQ (2014) Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis. Lupus 23:284–292.PubMedCrossRef
18.
Zurück zum Zitat Shimizu M, Kawata M, Okada T, Yuu H, Kurahashi T, Yamanaka K, Umezu K (2002) Concomitant Cushing’s syndrome due to adrenal adenoma in a patient with systemic lupus erythematosus. Intern Med 41:1044–1046.PubMedCrossRef Shimizu M, Kawata M, Okada T, Yuu H, Kurahashi T, Yamanaka K, Umezu K (2002) Concomitant Cushing’s syndrome due to adrenal adenoma in a patient with systemic lupus erythematosus. Intern Med 41:1044–1046.PubMedCrossRef
19.
Zurück zum Zitat Lin AT, Min Y, Clements PJ, Morris R, Shayestehfar B, Mankin L, Wong AL (2002) New onset systemic lupus erythematosus with pheochromocytoma. J Rheumatol 29 :1334–1337.PubMed Lin AT, Min Y, Clements PJ, Morris R, Shayestehfar B, Mankin L, Wong AL (2002) New onset systemic lupus erythematosus with pheochromocytoma. J Rheumatol 29 :1334–1337.PubMed
20.
Zurück zum Zitat Boland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, McNicholas MM, Mueller PR (1995) Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 194:131–134.PubMedCrossRef Boland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, McNicholas MM, Mueller PR (1995) Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 194:131–134.PubMedCrossRef
21.
Zurück zum Zitat Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A (2001) 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42:1795–1799.PubMed Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A (2001) 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42:1795–1799.PubMed
22.
Zurück zum Zitat Aide N, Cappele O, Bottet P, Bensadoun H, Regeasse A, Comoz F, Sobrio F, Bouvard G, Agostini D (2003) Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 30:1236–1245.PubMedCrossRef Aide N, Cappele O, Bottet P, Bensadoun H, Regeasse A, Comoz F, Sobrio F, Bouvard G, Agostini D (2003) Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 30:1236–1245.PubMedCrossRef
23.
Zurück zum Zitat Kochhar R, Brown RK, Wong CO, Dunnick NR, Frey KA, Manoharan P (2010) Role of FDG PET/CT in imaging of renal lesions. J Med Imaging Radiat Oncol 54:347–357.PubMedCrossRef Kochhar R, Brown RK, Wong CO, Dunnick NR, Frey KA, Manoharan P (2010) Role of FDG PET/CT in imaging of renal lesions. J Med Imaging Radiat Oncol 54:347–357.PubMedCrossRef
24.
Zurück zum Zitat Terui K, Sakihara S, Kageyama K, Nigawara T, Takayasu S, Matsuhashi Y, Kon A, Yamamoto H, Ohyama C, Sasano H, Suda T (2010) A case of adrenocortical oncocytoma occurring with aldosteronoma. J Clin Endocrinol Metab 95:3597–3598.PubMedCrossRef Terui K, Sakihara S, Kageyama K, Nigawara T, Takayasu S, Matsuhashi Y, Kon A, Yamamoto H, Ohyama C, Sasano H, Suda T (2010) A case of adrenocortical oncocytoma occurring with aldosteronoma. J Clin Endocrinol Metab 95:3597–3598.PubMedCrossRef
25.
Zurück zum Zitat Son SH, Lee SW, Song BI, Jang YJ, Park JY, Jeong SY, Ahn BC, Lee J (2014) Recurrence of a functional adrenocortical oncocytoma of borderline malignant potential showing high FDG uptake on 18F-FDG PET/CT. Ann Nucl Med 28:69–73.PubMedCrossRef Son SH, Lee SW, Song BI, Jang YJ, Park JY, Jeong SY, Ahn BC, Lee J (2014) Recurrence of a functional adrenocortical oncocytoma of borderline malignant potential showing high FDG uptake on 18F-FDG PET/CT. Ann Nucl Med 28:69–73.PubMedCrossRef
26.
Zurück zum Zitat Kobayashi M, Kaida H, Kawahara A, Hattori S, Kurata S, Hayakawa M, Hirose Y, Uchida M, Kage M, Fujita H, Hayabuchi N, Ishibashi M (2012) The relationship between GLUT-1 and vascular endothelial growth factor expression and 18F-FDG uptake in esophageal squamous cell cancer patients. Clin Nucl Med 37:447–452.PubMedCrossRef Kobayashi M, Kaida H, Kawahara A, Hattori S, Kurata S, Hayakawa M, Hirose Y, Uchida M, Kage M, Fujita H, Hayabuchi N, Ishibashi M (2012) The relationship between GLUT-1 and vascular endothelial growth factor expression and 18F-FDG uptake in esophageal squamous cell cancer patients. Clin Nucl Med 37:447–452.PubMedCrossRef
27.
Zurück zum Zitat Tong SY, Lee JM, Ki KD, Choi YJ, Seol HJ, Lee SK, Huh CY, Kim GY, Lim SJ (2012) Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer. Int J Gynecol Cancer 22:654–658.PubMedCrossRef Tong SY, Lee JM, Ki KD, Choi YJ, Seol HJ, Lee SK, Huh CY, Kim GY, Lim SJ (2012) Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer. Int J Gynecol Cancer 22:654–658.PubMedCrossRef
28.
Zurück zum Zitat Deron P, Vangestel C, Goethals I, De Potter A, Peeters M, Vermeersch H, Van de Wiele C (2011) FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis. Nuklearmedizin 50:15–21.PubMedCrossRef Deron P, Vangestel C, Goethals I, De Potter A, Peeters M, Vermeersch H, Van de Wiele C (2011) FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis. Nuklearmedizin 50:15–21.PubMedCrossRef
29.
Zurück zum Zitat Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M (2012) (1)(8)FDG PET for grading malignancy in thymic epithelial tumors: significant differences in (1)(8)FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study. Eur J Radiol 81:146–151.PubMedCrossRef Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M (2012) (1)(8)FDG PET for grading malignancy in thymic epithelial tumors: significant differences in (1)(8)FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study. Eur J Radiol 81:146–151.PubMedCrossRef
30.
Zurück zum Zitat Wu T, Pan T, Zheng Z, Chen T, Pan Y (2008) Relationship between Glut-1, Glut-3 expression and fluorodeoxyglucose uptake in NSCLC and benign pulmonary lesion. Zhongguo Fei Ai Za Zhi 11:555–558.PubMed Wu T, Pan T, Zheng Z, Chen T, Pan Y (2008) Relationship between Glut-1, Glut-3 expression and fluorodeoxyglucose uptake in NSCLC and benign pulmonary lesion. Zhongguo Fei Ai Za Zhi 11:555–558.PubMed
31.
Zurück zum Zitat Abdulla S, Salavati A, Saboury B, Basu S, Torigian DA, Alavi A (2014) Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study. Eur J Nucl Med Mol Imaging 41:350–356.PubMedCrossRef Abdulla S, Salavati A, Saboury B, Basu S, Torigian DA, Alavi A (2014) Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study. Eur J Nucl Med Mol Imaging 41:350–356.PubMedCrossRef
32.
Zurück zum Zitat Tan GJ, Berlangieri SU, Lee ST, Scott AM (2014) FDG PET/CT in the liver: lesions mimicking malignancies. Abdom Imaging 39:187–195.PubMedCrossRef Tan GJ, Berlangieri SU, Lee ST, Scott AM (2014) FDG PET/CT in the liver: lesions mimicking malignancies. Abdom Imaging 39:187–195.PubMedCrossRef
33.
Zurück zum Zitat Nakamura Y, Hornsby PJ, Casson P, Morimoto R, Satoh F, Xing Y, Kennedy MR, Sasano H, Rainey WE (2009) Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab 94:2192–2198.PubMedCentralPubMedCrossRef Nakamura Y, Hornsby PJ, Casson P, Morimoto R, Satoh F, Xing Y, Kennedy MR, Sasano H, Rainey WE (2009) Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab 94:2192–2198.PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Sasano H, Mason JI, Sasaki E, Yajima A, Kimura N, Namiki T, Sasano N, Nagura H (1990) Immunohistochemical study of 3 beta-hydroxysteroid dehydrogenase in sex cord-stromal tumors of the ovary. Int J Gynecol Pathol 9:352–362.PubMedCrossRef Sasano H, Mason JI, Sasaki E, Yajima A, Kimura N, Namiki T, Sasano N, Nagura H (1990) Immunohistochemical study of 3 beta-hydroxysteroid dehydrogenase in sex cord-stromal tumors of the ovary. Int J Gynecol Pathol 9:352–362.PubMedCrossRef
Metadaten
Titel
Case Report: Adrenal Oncocytoma Associated with Markedly Increased FDG Uptake and Immunohistochemically Positive for GLUT1
verfasst von
Naomi Sato
Yasuhiro Nakamura
Kentaro Takanami
Yoshikiyo Ono
Kei Omata
Ryo Morimoto
Fumitoshi Satoh
Kazue Ise
Shigeyuki Yamada
Atsuko Kasajima
Fumiyoshi Fujishima
Mika Watanabe
Yoichi Arai
Hironobu Sasano
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 4/2014
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-014-9337-4

Weitere Artikel der Ausgabe 4/2014

Endocrine Pathology 4/2014 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …